These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3792217

  • 1. Effects of levels of feed restriction on in vivo and in vitro alterations in drug metabolism and associated enzymes.
    Sachan DS, Su PK.
    Drug Nutr Interact; 1986; 4(4):363-70. PubMed ID: 3792217
    [Abstract] [Full Text] [Related]

  • 2. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE, Evans JS, Holmes D, Baker MT.
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [Abstract] [Full Text] [Related]

  • 3. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
    Sonawane BR, Coates PM, Yaffe SJ, Koldovsky O.
    Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
    [Abstract] [Full Text] [Related]

  • 4. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes.
    Naraharisetti SB, Aggarwal M, Sarkar SN, Malik JK.
    Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686
    [Abstract] [Full Text] [Related]

  • 5. Effect of manganese on hepatic drug metabolism in male and female rats.
    Schnell RC, Deimling MJ.
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):307-15. PubMed ID: 6709965
    [Abstract] [Full Text] [Related]

  • 6. Influence of the combined chemotherapeutic drug tuboprim on drug metabolism.
    Mitcheva M, Staneva-Stoytcheva D.
    Acta Physiol Pharmacol Bulg; 1988 Feb; 14(1):35-41. PubMed ID: 3407414
    [Abstract] [Full Text] [Related]

  • 7. Hepatic mono-oxygenase activity and hepatocellular morphology in chickens treated with 3-methylcholanthrene.
    Buynitzky SJ, Wade AE, Munnell JF, Ragland WL.
    Drug Metab Dispos; 1978 Feb; 6(1):1-7. PubMed ID: 23267
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of hepatic drug-metabolizing enzymes by arachidonic acid.
    Pessayre D, Mazel P, Descatoire V, Rogier E, Feldmann G, Benhamou JP.
    Xenobiotica; 1979 May; 9(5):301-10. PubMed ID: 115160
    [Abstract] [Full Text] [Related]

  • 9. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A, Dani V, Dhawan DK.
    Toxicol Lett; 2007 Feb 28; 169(1):26-33. PubMed ID: 17194553
    [Abstract] [Full Text] [Related]

  • 10. Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet.
    Gadeholt G, Aarbakke J, Dybing E, Sjöblom M, Mørland J.
    J Pharmacol Exp Ther; 1980 Apr 28; 213(1):196-203. PubMed ID: 6102148
    [Abstract] [Full Text] [Related]

  • 11. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y, Nakahara M, Kohno M, Otsuka M, Takaiti O.
    Arzneimittelforschung; 1989 Mar 28; 39(3):356-60. PubMed ID: 2502989
    [Abstract] [Full Text] [Related]

  • 12. Depression of the hepatic cytochrome P-450 monooxygenase system by treatment of mice with the antineoplastic agent 5-azacytidine.
    Gooderham NJ, Mannering GJ.
    Cancer Res; 1985 Apr 28; 45(4):1569-72. PubMed ID: 2579731
    [Abstract] [Full Text] [Related]

  • 13. Dietary influences on the hepatic mixed-function oxidase system in the rat after portacaval anastomosis.
    Proia AD, Edwards KD, McNamara DJ, Anderson KE.
    Gastroenterology; 1984 Apr 28; 86(4):618-26. PubMed ID: 6698363
    [Abstract] [Full Text] [Related]

  • 14. Effect of hepatic microsomal mixed-function oxidase activities in rats pretreated with Nocardia rubra cell wall skeleton.
    Iwasaki K, Noguchi H.
    Res Commun Chem Pathol Pharmacol; 1982 Aug 28; 37(2):267-77. PubMed ID: 7134631
    [Abstract] [Full Text] [Related]

  • 15. Normal levels of hepatic drug-metabolizing enzymes in neonatally induced, growth hormone-deficient adult male and female rats.
    Shapiro BH, Albucher RC, MacLeod JN, Bitar MS.
    Drug Metab Dispos; 1986 Aug 28; 14(5):585-9. PubMed ID: 2876866
    [Abstract] [Full Text] [Related]

  • 16. Effect of experimental diabetes on drug metabolism in the rat.
    Ackerman DM, Leibman KC.
    Drug Metab Dispos; 1977 Aug 28; 5(4):405-10. PubMed ID: 19220
    [Abstract] [Full Text] [Related]

  • 17. Interaction of endosulfan and dietary vitamin A on rat hepatic drug metabolising enzymes.
    Sriram K, Misra UK.
    Acta Vitaminol Enzymol; 1983 Aug 28; 5(4):213-8. PubMed ID: 6424426
    [Abstract] [Full Text] [Related]

  • 18. Portal vein ligation selectively lowers hepatic cytochrome P450 levels in rats.
    Farrell GC, Zaluzny L.
    Gastroenterology; 1983 Aug 28; 85(2):275-82. PubMed ID: 6862153
    [Abstract] [Full Text] [Related]

  • 19. The effect of aspartame on the activity of rat liver xenobiotic-metabolizing enzymes.
    Tutelyan VA, Kravchenko LV, Kuzmina EE.
    Drug Metab Dispos; 1990 Aug 28; 18(2):223-5. PubMed ID: 1971577
    [Abstract] [Full Text] [Related]

  • 20. Persistent defects in the hepatic monooxygenase system of adult rats exposed, perinatally, to maternally administered phenytoin.
    Shapiro BH, Lech GM, Bardales RM.
    J Pharmacol Exp Ther; 1986 Jul 28; 238(1):68-75. PubMed ID: 3723406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.